Published in Schizophr Bull on May 16, 2010
A meta-analysis of sex differences in human brain structure. Neurosci Biobehav Rev (2013) 1.28
Trait and state attributes of insight in first episodes of early-onset schizophrenia and other psychoses: a 2-year longitudinal study. Schizophr Bull (2010) 0.92
Structural and functional neuroimaging studies in major depressive disorder with psychotic features: a critical review. Schizophr Bull (2013) 0.88
Gray matter alterations in schizophrenia high-risk youth and early-onset schizophrenia: a review of structural MRI findings. Child Adolesc Psychiatr Clin N Am (2013) 0.86
Differential neurodevelopmental trajectories in patients with early-onset bipolar and schizophrenia disorders. Schizophr Bull (2013) 0.83
Gender effects on brain changes in early-onset psychosis. Eur Child Adolesc Psychiatry (2015) 0.76
Sexual dimorphism of brain developmental trajectories during childhood and adolescence. Neuroimage (2007) 5.86
Multimodal image coregistration and partitioning--a unified framework. Neuroimage (1997) 4.26
Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proc Natl Acad Sci U S A (2001) 3.45
Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism. Am J Psychiatry (1998) 2.53
Clinical subtypes of schizophrenia: differences in brain and CSF volume. Am J Psychiatry (1994) 2.27
Brain gray and white matter volume loss accelerates with aging in chronic alcoholics: a quantitative MRI study. Alcohol Clin Exp Res (1992) 2.25
A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures. Arch Gen Psychiatry (1998) 2.24
Childhood-onset schizophrenia. Progressive ventricular change during adolescence. Arch Gen Psychiatry (1997) 2.15
Automatic atlas-based volume estimation of human brain regions from MR images. J Comput Assist Tomogr (1996) 1.99
Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder. Arch Gen Psychiatry (2008) 1.96
What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia. Schizophr Bull (2008) 1.80
Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Arch Gen Psychiatry (1992) 1.76
Cortical thinning in cingulate and occipital cortices in first episode schizophrenia. Biol Psychiatry (2005) 1.63
Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood. Biol Psychiatry (2007) 1.58
Correlations between rCBF and symptoms in two independent cohorts of drug-free patients with schizophrenia. Neuropsychopharmacology (2006) 1.53
Automated Talairach atlas-based parcellation and measurement of cerebral lobes in children. Psychiatry Res (1999) 1.51
Progressive brain volume loss during adolescence in childhood-onset schizophrenia. Am J Psychiatry (2003) 1.46
Childhood onset schizophrenia: cortical brain abnormalities as young adults. J Child Psychol Psychiatry (2006) 1.43
Ventricular and periventricular structural volumes in first- versus multiple-episode bipolar disorder. Am J Psychiatry (2002) 1.40
Regional brain morphometry in patients with schizophrenia or bipolar disorder and their unaffected relatives. Am J Psychiatry (2006) 1.35
Assessment of the increase in variability when combining volumetric data from different scanners. Hum Brain Mapp (2009) 1.30
Comparison of progressive cortical gray matter loss in childhood-onset schizophrenia with that in childhood-onset atypical psychoses. Arch Gen Psychiatry (2004) 1.21
Childhood-onset schizophrenia: the severity of premorbid course. J Am Acad Child Adolesc Psychiatry (1995) 1.21
Adult outcomes of child- and adolescent-onset schizophrenia: diagnostic stability and predictive validity. Am J Psychiatry (2000) 1.12
MRI study of posterior fossa structures and brain ventricles in bipolar patients. J Psychiatr Res (2001) 1.07
Cerebellar, prefrontal cortex, and thalamic volumes over two time points in adolescent-onset schizophrenia. Am J Psychiatry (2004) 1.07
Does diagnostic classification of early-onset psychosis change over follow-up? Child Psychiatry Hum Dev (2007) 1.00
The child and adolescent first-episode psychosis study (CAFEPS): design and baseline results. Schizophr Res (2007) 0.99
Association between reduced duration mismatch negativity (MMN) and raised temporal discrimination thresholds in schizophrenia. Clin Neurophysiol (2003) 0.97
Effects of image orientation on the comparability of pediatric brain volumes using three-dimensional MR data. J Comput Assist Tomogr (2001) 0.96
Evidence for non-progressive changes in adolescent-onset schizophrenia: follow-up magnetic resonance imaging study. Br J Psychiatry (2002) 0.91
Progression of brain volume changes in adolescent-onset psychosis. Schizophr Bull (2008) 0.90
Structural neuroimaging in adolescents with a first psychotic episode. J Am Acad Child Adolesc Psychiatry (2005) 0.88
Progressive brain changes in schizophrenia. Schizophr Bull (2008) 0.87
Patterns of cranial, brain and sulcal CSF volumes in male and female deficit and nondeficit patients with schizophrenia. Psychiatry Res (2008) 0.84
Brain abnormalities observed in childhood-onset schizophrenia: a review of the structural magnetic resonance imaging literature. Ment Retard Dev Disabil Res Rev (2000) 0.80
Intracranial CSF volumes: natural variations and physiological changes measured by MRI. Acta Neurochir Suppl (Wien) (1988) 0.78
Common variants conferring risk of schizophrenia. Nature (2009) 10.37
Synaptic, transcriptional and chromatin genes disrupted in autism. Nature (2014) 5.30
Cognition in schizophrenia: summary Nice Consultation Meeting 2012. Eur Neuropsychopharmacol (2013) 3.99
Predictors of suicide attempt in early-onset, first-episode psychoses: a longitudinal 24-month follow-up study. J Clin Psychiatry (2012) 3.45
The chronic bronchitis phenotype in subjects with and without COPD: the PLATINO study. Eur Respir J (2012) 2.79
Depression in bipolar disorder versus major depressive disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Bipolar Disord (2012) 2.47
Morphometric assessment of the heteromodal association cortex in schizophrenia. Am J Psychiatry (2004) 2.27
Common variants at VRK2 and TCF4 conferring risk of schizophrenia. Hum Mol Genet (2011) 2.21
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry (2013) 1.97
Brain effects of cognitive remediation therapy in schizophrenia: a structural and functional neuroimaging study. Biol Psychiatry (2013) 1.95
The continuum of psychotic symptoms in the general population: a cross-national study. Schizophr Bull (2010) 1.94
Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: results of the CLAMORS Study. Schizophr Res (2006) 1.88
Efficacy of functional remediation in bipolar disorder: a multicenter randomized controlled study. Am J Psychiatry (2013) 1.75
ROAMER: roadmap for mental health research in Europe. Int J Methods Psychiatr Res (2014) 1.67
Spatio-temporal nonrigid registration for ultrasound cardiac motion estimation. IEEE Trans Med Imaging (2005) 1.66
Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study. J Clin Psychiatry (2009) 1.61
Concordance of standard and modified NCEP ATP III criteria for identification of metabolic syndrome in outpatients with schizophrenia treated with antipsychotics: a corollary from the CLAMORS study. Schizophr Res (2007) 1.47
Comorbidity and phenomenology of bipolar disorder in children with ADHD. J Atten Disord (2012) 1.46
Serum IgG antibodies against the NR1 subunit of the NMDA receptor not detected in schizophrenia. Am J Psychiatry (2012) 1.46
Long chain omega-3 fatty acids intake, fish consumption and mental disorders in the SUN cohort study. Eur J Nutr (2007) 1.45
Waking-like brain function in embryos. Curr Biol (2012) 1.41
Sustained attention impairment correlates to gray matter decreases in first episode neuroleptic-naive schizophrenic patients. Neuroimage (2003) 1.36
Antipsychotics in children and adolescents: increasing use, evidence for efficacy and safety concerns. Eur Neuropsychopharmacol (2009) 1.36
Significance and meaning of neurological signs in schizophrenia: two decades later. Schizophr Bull (2005) 1.34
A cross-sectional and follow-up voxel-based morphometric MRI study in adolescent anorexia nervosa. J Psychiatr Res (2008) 1.31
Assessment of the increase in variability when combining volumetric data from different scanners. Hum Brain Mapp (2009) 1.30
Diagnostic labeling of COPD in five Latin American cities. Chest (2007) 1.26
Brain connectivity during resting state and subsequent working memory task predicts behavioural performance. Cortex (2011) 1.26
Tracking of regions-of-interest in myocardial contrast echocardiography. Ultrasound Med Biol (2004) 1.21
ECNP consensus meeting. Bipolar depression. Nice, March 2007. Eur Neuropsychopharmacol (2008) 1.21
18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation. Int J Radiat Oncol Biol Phys (2004) 1.20
Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: comprehensive review of prospective head-to-head and placebo-controlled comparisons. Eur Neuropsychopharmacol (2010) 1.20
Hippocampal head atrophy after traumatic brain injury. Neuropsychologia (2005) 1.20
Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice. Eur Neuropsychopharmacol (2009) 1.19
Incidence and risk factors for ventilator-associated pneumonia after major heart surgery. Intensive Care Med (2009) 1.19
Increased cortical thickness and caudate volume precede atrophy in PSEN1 mutation carriers. J Alzheimers Dis (2010) 1.18
Cannabis and first-episode psychosis: different long-term outcomes depending on continued or discontinued use. Schizophr Bull (2009) 1.17
The chemokine receptor CXCR4 and the metalloproteinase MT1-MMP are mutually required during melanoma metastasis to lungs. Am J Pathol (2009) 1.17
New treatment guidelines for acute bipolar depression: a systematic review. J Affect Disord (2010) 1.15
TAR DNA-Binding protein 43 accumulation in protein aggregate myopathies. J Neuropathol Exp Neurol (2009) 1.15
Decreased cerebral activation during CPT performance: structural and functional deficits in schizophrenic patients. Neuroimage (2004) 1.13
Low level of dopaminergic D2 receptor binding in obsessive-compulsive disorder. Biol Psychiatry (2004) 1.12
Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations. Schizophr Bull (2014) 1.10
Metabolic and hormonal side effects in children and adolescents treated with second-generation antipsychotics. J Clin Psychiatry (2008) 1.10
Increase in gray matter and decrease in white matter volumes in the cortex during treatment with atypical neuroleptics in schizophrenia. Schizophr Res (2005) 1.09
Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: an analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort. Schizophr Res (2010) 1.09
Neuroanatomical substrate of visuospatial and visuoperceptual impairment in Parkinson's disease. Mov Disord (2009) 1.09
The novel DNA methylation inhibitor zebularine is effective against the development of murine T-cell lymphoma. Blood (2005) 1.09
Child and adolescent psychiatry: the need for training and development. Rev Psiquiatr Salud Ment (2012) 1.07
Psychotic symptoms are associated with physical health problems independently of a mental disorder diagnosis: results from the WHO World Health Survey. World Psychiatry (2013) 1.07
Longitudinal brain changes in early-onset psychosis. Schizophr Bull (2008) 1.06
Increased glutamate/glutamine compounds in the brains of patients with fibromyalgia: a magnetic resonance spectroscopy study. Arthritis Rheum (2010) 1.06
Hippocampal head atrophy predominance in Parkinson's disease with hallucinations and with dementia. J Neurol (2008) 1.05
The expression of GLP-1 receptor mRNA and protein allows the effect of GLP-1 on glucose metabolism in the human hypothalamus and brainstem. J Neurochem (2005) 1.05
Reduced antioxidant defense in early onset first-episode psychosis: a case-control study. BMC Psychiatry (2011) 1.03
Proteasomal expression, induction of immunoproteasome subunits, and local MHC class I presentation in myofibrillar myopathy and inclusion body myositis. J Neuropathol Exp Neurol (2004) 1.03
Gyral and sulcal cortical thinning in adolescents with first episode early-onset psychosis. Biol Psychiatry (2009) 1.03
Chronic obstructive pulmonary disease and body mass index in five Latin America cities: the PLATINO study. Respir Med (2008) 1.02
Constitutive activation of B-Raf in the mouse germ line provides a model for human cardio-facio-cutaneous syndrome. Proc Natl Acad Sci U S A (2011) 1.02
Transcription-terminating mutation in telethonin causing autosomal recessive muscular dystrophy type 2G in a European patient. Neuromuscul Disord (2008) 1.02
Bipolar disorder in children and adolescents: international perspective on epidemiology and phenomenology. Bipolar Disord (2005) 1.02
Progressive brain changes in children and adolescents with first-episode psychosis. Arch Gen Psychiatry (2012) 1.02
Decreased levels of plasma BDNF in first-episode schizophrenia and bipolar disorder patients. Schizophr Res (2006) 1.01
Does diagnostic classification of early-onset psychosis change over follow-up? Child Psychiatry Hum Dev (2007) 1.00